Tekla Life Sciences Inves... (HQL)

AI Score

Unlock

11.80

0.14 (1.20%)

At close: Apr 17, 2025, 3:59 PM

Tekla Life Sciences Investors Cash Flow Statement

Financials in USD. Fiscal year is October - September.

Fiscal Year	Q4 2024	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Sep 30, 2024	Mar 30, 2024	Sep 30, 2023	Mar 31, 2023	Sep 30, 2022	Mar 30, 2022	Sep 30, 2021	Mar 30, 2021	Sep 30, 2020	Mar 30, 2020	Sep 30, 2019	Mar 30, 2019	Sep 30, 2018	Mar 30, 2018	Sep 30, 2017	Mar 30, 2017	Sep 30, 2016	Mar 30, 2016
Net Income	n/a	n/a	11.18M	33.8M	-52.3K	-52.3K	32.27K	32.27K	61.53K	61.53K	-35.24K	-35.24K	14.33K	14.33K	34.28K	34.28K	-5.96K	-5.96K
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Working Capital	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Non-Cash Items	n/a	n/a	-11.18M	-33.8M	52.3K	52.3K	-32.27K	-32.27K	-61.53K	-61.53K	35.24K	35.24K	-14.33K	-14.33K	-34.28K	-34.28K	5.96K	5.96K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	-0.37	-0.37	n/a	n/a	-0.31	-0.31	n/a	n/a	n/a	n/a	n/a	n/a
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Financial Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Net Cash Flow	n/a	n/a	32.00	n/a	-545	-545	-0.74	-0.74	n/a	n/a	1.12M	1.12M	n/a	n/a	n/a	n/a	n/a	n/a
Free Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	-0.37	-0.37	n/a	n/a	-0.31	-0.31	n/a	n/a	n/a	n/a	n/a	n/a